Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  62,403 results for ""Deoxycytidine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Raman imaging for monitoring deuterated squalene-gemcitabine nanomedicines in single living breast cancer cells.

  • Authors : Al Assaad A; Université de Reims Champagne Ardenne, BioSpecT- UR 7506, UFR de Pharmacie, 51096, Reims, France.; Alaouta C

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/chemistry

  • Source: International journal of pharmaceutics [Int J Pharm] 2024 Dec 25; Vol. 667 (Pt A), pp. 124870. Date of Electronic Publication: 2024 Oct 26.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Robust Bisulfite-Free Single-Molecule Real-Time Sequencing of Methyldeoxycytidine Based on a Novel hpTet3 Enzyme.

  • Authors : Sahin H; Center for Nucleic Acid Therapies at the Department of Chemistry, Institute for Chemical Epigenetics, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, 81377, München, Germany.; Salehi R

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/chemistry ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/metabolism

  • Source: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2024 Dec 20; Vol. 63 (52), pp. e202418500. Date of Electronic Publication: 2024 Nov 25.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 0370543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3773

Record details

Read More Add to Saved list
×
Academic Journal

Targeting ketone body metabolism in mitigating gemcitabine resistance.

  • Authors : Rohena-Rivera K; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Samuel Oschin Cancer Center, Los Angeles, California, USA.

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: JCI insight [JCI Insight] 2024 Dec 20; Vol. 9 (24). Date of Electronic Publication: 2024 Dec 20.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Improved Antitumor Efficiency of N 4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy.

  • Authors : Wang D; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People's Republic of China.; Wang X

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/chemistry ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: International journal of nanomedicine [Int J Nanomedicine] 2024 Dec 11; Vol. 19, pp. 13391-13410. Date of Electronic Publication: 2024 Dec 11 (Print Publication: 2024).Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Hand therapy interventions for the prevention of chemotherapy-induced peripheral neuropathy of the hands in patients with pancreatic cancer.

  • Authors : Jameson GS; HonorHealth Research Institute, Scottsdale, AZ, United States.; Cooper C

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/adverse effects ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/therapeutic use

  • Source: The oncologist [Oncologist] 2024 Dec 06; Vol. 29 (12), pp. 1095-e1778.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.

  • Authors : Reichinger A; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology, and Medical Oncology, Ordensklinikum Linz - Barmherzige Schwestern Site, Seilerstaette 4, 4020 Linz,Austria.; Medical Faculty, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; Cisplatin*/Cisplatin*/Cisplatin*/therapeutic use ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use

  • Source: The oncologist [Oncologist] 2024 Dec 06; Vol. 29 (12), pp. 1090-1094.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Chemotherapy and radiotherapy for advanced pancreatic cancer.

  • Authors : Haggstrom L; Medical Oncology, The Kinghorn Cancer Care Centre, St Vincent's Hospital, Sydney, Australia.; Medical Oncology, Illawarra Shoalhaven Local Health District, Wollongong, Australia.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/therapeutic use

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Dec 05; Vol. 12. Cochrane AN: CD011044. Date of Electronic Publication: 2024 Dec 05.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

Read More Add to Saved list
×
Academic Journal

Pembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in Malaysia.

  • Authors : Cheong SC; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Oral & Maxillofacial Clinical Sciences, Faculty of Dentistry, Universiti Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: BMJ open [BMJ Open] 2024 Dec 03; Vol. 14 (12), pp. e076898. Date of Electronic Publication: 2024 Dec 03.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer.

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage ; Paclitaxel*/Paclitaxel*/Paclitaxel*/adverse effects ; Gemcitabine*

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 02; Vol. 30 (23), pp. 5293-5303.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.

  • Authors : Dhir A; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida.; Hayashi M

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/drug therapy ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/mortality

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 02; Vol. 30 (23), pp. 5314-5322.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  62,403 results for ""Deoxycytidine""